Minimally differentiated acute myeloid leukemia in Taiwan: Predominantly occurs in children less than 3 years and adults between 51 and 70 years

Leukemia

Volumn 13, Issue 10, 1999, Pages 1506-1512

  Huang, S Y ^a   Tang, J L ^a   Jou, S T ^a   Tsay, W ^a   Hu, C H ^a   Lin, D T ^a   Lin, K S ^a   Wang, C H ^a   Chen, Y C ^a   Shen, M C ^a   Tien, H F ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

AML; MO; Taiwan

Indexed keywords

ANTHRACYCLINE; CD34 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER CLASSIFICATION; CANCER SURVIVAL; CHILD; CYTOGENETICS; DIFFERENTIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; TAIWAN;

EID: 0032826317     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401521     Document Type: Article

References (31)

1. Lee EJ, Pollak A, Leavitt RD, Testa JR, Schiffer CA. Minimally differentiated acute nonlymphocytic leukemia: a distinct entity. Blood 1987; 70: 1400-1406.
2. Hara J, Yumura-Yagi K, Tawa A, Ishihara S, Murata M, Terada N, Izumi Y, Champagne E, Takihara Y, Mak TW, Minden M, Keisei KH. Molecular analysis of acute undifferentiated leukemia: two distinct subgroups at the DNA and RNA levels. Blood 1989; 74: 1738-1746.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991; 78: 325-329.
4. Hell G, Ganser A, Raghavachar A, Kurrle E, Heit W, Hoelzer D, Heimpel H. Induction of myeloperoxidase in five cases of acute unclassified leukaemia. Br J Haematol 1988; 68: 23-32.
5. van der Schoot CE, Daams GM, Pinkster J, Vet R, Kr von dem Borne AEG. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. Br J Haematol 1990; 74: 173-178.
6. Amadori S, Venditti A, Del Poeta G, Stasi R, Buccisano F, Bruno A, Tamburini A, Cox MC, Maffei L, Aronica G, Simone MD, Adorno G, Masi M, Tribalto M, Papa G. Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosis. Ann Hematol 1996; 72: 208-215.
7. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473-476.
8. Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, Orshoven AV, Criel A, Stul M, Cin PD, Hernandez J, Chatelain B, Doyen C, Louwagie A, Castoldi G, Cassiman JJ, van den Berghe H. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood 1995; 85: 3688-3694.
9. Del Poeta G, Stasi R, Aronica G, Venditti A, Cox MC, Bruno A, Buccisano F, Masi M, Tribalto M, Amadori S, Papa G. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 1996; 87: 1997-2004.
10. Segeren CM, de Jong-Gerrits GCMM, van't Veer MB. AML-M0: clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Ann Hematol 1995; 70: 297-300.
11. Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood 1994; 83: 1619-1625.
12. Huang SY, Tang JL, Liang YJ, Wang CH, Chen YC, Tien HF. Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): a study of four Chinese patients in Taiwan. Br J Haematol 1997; 96: 682-687.
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 620-625.
14. Mitelman F (ed.). ISCN (1995). An International System for Human Cytogenetic Nomenclature. Published in collaboration with Cytogenetics and Cell Genetics. S Karger: Basel.
15. Tien HF, Wang CH, Su IJ, Wu HS, Chien SH, Chen YC, Lin DT, Lin KH, Shen MC. Immunoglobulin and T-cell receptor gene rearrangement in acute lymphoblastic leukemia - a higher incidence of double rearrangements in patients with myeloid antigen expression. Leukemia Res 1991; 15: 91-98.
16. Sempere A, Jarque L, Guinot M, Palau J, Garcia R, Sanz GF, Gomis F, Perez-Sirvent ML, Senent L, Sanz MA. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases. Leuk Lymphoma 1993; 12: 103-108.
17. Traweek ST, Liu J, Braziel RM, lohnson RM, Brynes RK. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization. Diagn Mol Pathol 1995; 4: 212-219.
18. Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox CM, Stasi R, Bruno A, Aronica G, Maffei L, Suppo G, Simone MD, Forte L, Cordero V, Postorino M, Tufilli V, Isacchi G, Masi M, Papa G, Amadori S. Minimal differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes. Blood 1997; 89: 621-629.
19. Zittoun RA, Mandelli F, Willemze R, Witte TD, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans ME, Dardenne M, Vegna ML, Petti MC, Solbu G, Suciu S. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
20. Tien HF, Wang CH. CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia. Leuk Lymphoma 1998; 31: 93-98.
21. Buccheri V, Matutes E, Dyer MJS, Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993; 7: 919-927.
22. Del Poeta G, Stasi R, Venditti A, Masi M, Papa G. CD7 expression in acute myeloid leukemia. Blood 1993; 82: 2929-2932.
23. Jensen AW, Hokland M, Jorgensen H, Justesen J, Ellegaard J, Hokland P. Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor β and δ rearrangements and course of disease suggestive of poor prognosis. Blood 1991; 78: 1292-1300.
24. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, Kyo T, Dohy H, Kamada N, Nasu K, Uchino H. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993; 81: 2399-2405.
25. + acute myeloid leukemia. Cancer Cenet Cytogenet 1994; 73: 69-74.
26. Lauria F, Raspadori D, Ventura MA, Rondelli D, Tura S. CD7 expression does not affect the prognosis in acute myeloid leukemia. Blood 1994; 83: 3097-3098.
27. Tien HF, Wang CH, Chen YC, Shen MC, Lin DT, Lin KH. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML. Leukemia 1993; 7: 688-695.
28. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL, Rai K, Lee EJ, Schiffer CA, Bloomfield CD. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991; 77: 2242-2250.
29. Venditti A, Del Poeta G, Stasi R, Masi M, Bruno A, Buccisano F, Cox C, Coppetelli U, Aronica G, Simone MD, Papa G, Tribalto M, Amadori S. Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br J Haematol 1994; 88: 784-793.
30. Yokose N, Ogata K, Ito T, Miyake K, An E, Inokuchi K, Yamada T, Gomi S, Tanabe Y, Ohki I, Kuwabara T, Hasegawa S, Shinohara T, Dan K, Nomura T. Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0) - a report on five cases and review of the literature. Ann Hematol 1993; 66: 67-70.
31. Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, Gold S, Sanders J, Neudorf S, Smith FO, Woods WG. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 1998; 91: 608-615.